Form CDC 57.210 CDC 57.210 HCW Prophylaxis/Treatment-Influenza

The National Healthcare Safety Network (NHSN)

57.210_HCWFluMedAdmin_BLANK

57.210 Healthcare Worker Prophylaxis/Treatment - Influenza

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date: xx/xx/20xx

www.cdc.gov/nhsn

Healthcare Worker Prophylaxis/Treatment

Influenza

Page 1 of 4

*required

Facility ID #:

Med Admin #:

Healthcare Worker Demographics

*HCW ID#:

*HCW Name, Last:

First:

Middle:

*Gender: F M Other

*Date of Birth: ____ / ____ /_______

*Work Location:

*Occupation:

Clinical Specialty:

Information about the Antiviral Medication

Infectious agent: Influenza

*For season: _____________________(specify years)

*Indication (select one)

*#

Influenza subtype

*Antiviral medication (Enter code from below)

*Start date

Stop date

*Adverse reactions

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Prophylaxis

Treatment


Seasonal

Non-seasonal

Unknown


___/___/____

mm dd yyyy

___/___/____

mm dd yyyy

Yes No

Don’t know

Antiviral medications




AMAN-amantadine (Symmetrel®)

RIMAN-rimantadine(Flumadine®)

ZANAM-zanamivir (Relenza®)

OSELT-oseltamivir (Tamiflu®)

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.210 (Front), v6.6

Healthcare Worker Influenza Antiviral Medication Administration

Page 2 of 4

Information about the Antiviral Medication (cont.)

Adverse reactions to antiviral medication #1: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #2: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #3: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #4: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis


Healthcare Worker Influenza Antiviral Medication Administration

Page 3 of 4

Information about the Antiviral Medication (cont.)

Adverse reactions to antiviral medication #5: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #6: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #7: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #8: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis


Healthcare Worker Influenza Antiviral Medication Administration

Page 4 of 4

Information about the Antiviral Medication (cont.)

Adverse reactions to antiviral medication #9: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Adverse reactions to antiviral medication #10: (check all that apply)

Acute respiratory failure

Hemorrhagic colitis

Pulmonary edema

Anaphylactic reaction

Hepatitis

Serious skin rash

Arrhythmia

Hypotension; orthostatic hypotension

Suicide or self-harm attempt

Behavior disturbances

Leukopenia; neutropenia

Swelling of face or tongue

Bronchospasm

Life threatening overdose

Syncope

Cardiac arrest

Liver function test elevation

Tachycardia

Cardiac failure

Mydriasis (in patients with untreated angle closure glaucoma)

Toxic epidermal necrolysis/Stevens Johnson Syndrome

Coma

Neuroleptic malignant syndrome with abrupt discontinuation or dose reduction

Urinary retention

Convulsions; seizure

Other: _______________

Delirium, delusions, stupor

Oropharyngeal edema


Erythema multiforme

Psychosis



Custom Fields

Label

Label

_________________________

____/____/_____

_______________________

____/____/_____

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

Comments



















File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAmy Schneider
File Modified0000-00-00
File Created2021-04-12

© 2024 OMB.report | Privacy Policy